[Half-life of (4-14C)oestradiol-17beta in vivo, and metabolism of (4-14C)oestrone and (4-14C)oestriol in vitro in normal subjects and in patients with liver cirrhosis (author's transl)].
D000410:Alanine Transaminase / Q000097:blood; D002250:Carbon Radioisotopes; D002458:Cell Fractionation; D002854:Chromatography, Paper; D003600:Cytosol / Q000378:metabolism; D004958:Estradiol / Q000097:blood* / Q000378:metabolism; D004964:Estriol / Q000097:blood* / Q000378:metabolism; D004970:Estrone / Q000097:blood* / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D008099:Liver / Q000166:cytology / Q000378:metabolism / Q000473:pathology; D008103:Liver Cirrhosis / Q000097:blood*; D008297:Male; D008862:Microsomes, Liver / Q000378:metabolism; D011485:Protein Binding; D011955:Receptors, Drug; D013056:Spectrophotometry, Ultraviolet; D013997:Time Factors; D014461:Ultracentrifugation
D002250:Carbon Radioisotopes; D011955:Receptors, Drug; D004970:Estrone; D004958:Estradiol; D000410:Alanine Transaminase; D004964:Estriol
Halbwertszeit von (4-14C)Ostradiol-17beta in vivo sowie Stoffwechsel von (4-14C)Ostron und (4-14C)Ostriol in vitro bei Lebergesunden und bei Patienten mit Lebercirrhose.